INS and type 1 diabetes mellitus: Clinical trials suggest that adjunctive GLP-1RAs may assist in achieving important goals in the management of T1D, including optimizing glycemia, reducing weight, increasing insulin sensitivity, and may confer cardio-, nephro- and vascular protection.